At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
532 nm KTP laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single-Center Prospective, Open-Label Study of the Excel V 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte
In Brief
A clinical study evaluating 532 nm KTP laser for Poikiloderma of Civatte and 4 related conditions. Completed, enrolled 24 participants across 1 site.
Detailed Summary
This study will evaluate the safety and efficacy of the Excel V 532 nm KTP laser for the treatment of dyschromia of the neck and/or chest (poikiloderma of Civatte).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPoikiloderma of Civatte, Dyschromia, Pigmentation Disorders, Telangiectasia, Photosensitivity Disorders
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2011
First PostedDec 2011
Primary CompletionMay 2013
TodayJul 2026
First PostedDec 14, 2011
Enrollment StartNov 1, 2011
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 14.5 years ago
Interventions
532 nm KTP laserdevice
Laser treatment sessions on the neck and/or chest